Pancreatic Cancer Research

ResearcherJiangsu Province HospitalActive in the last 2 years

Jie Mei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7799-8129; OpenAlex author ID A5013365903. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 4

  1. Formin protein DAAM1 positively regulates PD-L1 expression via mediating the JAK1/STAT1 axis in pancreatic cancer. Co-author DOI 10.1186/s12935-024-03631-8↗
  2. PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer. Co-author DOI 10.2147/pgpm.s418533↗
  3. NEUROD1 predicts better prognosis in pancreatic cancer revealed by a TILs-based prognostic signature. Co-author DOI 10.3389/fphar.2022.1025921↗
  4. Profiles and clinical significance of immune cell infiltration in pancreatic adenocarcinoma Co-author DOI 10.1101/2020.03.30.017327↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rui Xu · 3 shared papers, 2020–2025 · strength 0.54
  2. Junli Ding · 2 shared papers, 2022–2023 · strength 0.34
  3. Junying Xu · 2 shared papers, 2022–2023 · strength 0.34
  4. Chaoying Liu · 2 shared papers, 2020–2022 · strength 0.28
  5. Jiayue Yang · 1 shared paper, 2025 · strength 0.26
  6. Jing Yi Sun · 1 shared paper, 2025 · strength 0.26
  7. Wei Huang · 1 shared paper, 2023 · strength 0.19
  8. Zhiyang Jiang · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.